Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the ocular hypotensive effect of the Hydrus Aqueous
Implant (Standard and Low-Profile), as determined by the change in IOP from baseline
(preoperative) and change in the number of glaucoma medications from baseline.